L'Oreal Launches First Battery-Free Wearable for UV Protection
In 1935 L'Oreal developed the first commercial sunscreen product. Now, the beauty company is out with the first battery-free wearable that help will with UV protection. UV Sense could usher in a new wave of preventative sun skin care.
Guive Balooch is the Global Vice President of L'Oréal's Technology Incubator. Balooch explains the importance of creating a wearable that is as fashionable as it is functional. UV Sense is the only wearable that has no battery. This makes the device small enough to fit on a consumer's fingernail.
Balooch says the key to creating a wearable that people want is to make it have actionable results and make it something fashionable that people want it to wear.
UV Sense is being piloted this year and should be officially launched for commercial purchasing in 2019.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
